Ketorolac Levels in Vitreous and Aqueous Samples From Patients Undergoing Combined Cataract and Pars Plana Vitrectomy Surgeries With and Without Intracameral Phenylephrine 1.0% / Ketorolac 0.3%
Early Phase 1
Recruiting
- Conditions
- Cataract
- Interventions
- Combination Product: OMIDRIA (*Registered Product) {10.16 mg/mL (1% w/v) of phenylephrine and 2.88 mg/mL (0.3% w/v) of ketorolac}Other: Ketorolac Tromethamine {TORADOL} (0.5%) - Topical Eyedrop
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- DHS Consulting
- Target Recruit Count
- 20
- Registration Number
- NCT06539637
- Locations
- 🇺🇸
Ophthalmic Consultants of Long Island, Westbury, New York, United States
© Copyright 2025. All Rights Reserved by MedPath